Cargando…

The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets

STS (soft tissue sarcomas) are rare malignant tumours deriving from cells of mesenchymal origin and represent only 1% of all malignant neoplasms. It has been extensively demonstrated that angiogenesis has an important role in cancer malignancy. Particularly, a lot of studies demonstrate the importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocchi, Laura, Caraffi, Stefano, Perris, Roberto, Mangieri, Domenica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219423/ https://www.ncbi.nlm.nih.gov/pubmed/25236925 http://dx.doi.org/10.1042/BSR20140075

Ejemplares similares

MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line
por: Alias, Carlotta, et al.
Publicado: (2015)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

Relationship of angiogenic and apoptotic activities in soft-tissue sarcoma
por: Win, Thin Thin, et al.
Publicado: (2014)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

The challenge of finding new therapeutic avenues in soft tissue sarcomas
por: Kasper, Bernd
Publicado: (2019)

Soft Tissue Sarcoma: New Paradigms in Care
por: Choong, Peter
Publicado: (2012)

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Martinez-Font, Esther, et al.
Publicado: (2021)

Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging
por: Lou, Sha, et al.
Publicado: (2016)

New Anti-angiogenic Leading Structure Discovered in the Fruit of Cimicifuga yunnanensis
por: Nian, Yin, et al.
Publicado: (2015)

Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019)

Angiogenesis goes computational – The future way forward to discover new angiogenic targets?
por: Subramanian, Abhishek, et al.
Publicado: (2022)

Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies
por: de Bree, Eelco, et al.
Publicado: (2023)

New drugs and combinations for the treatment of soft-tissue sarcoma: a review
por: Somaiah, Neeta, et al.
Publicado: (2012)

Olaratumab: A New Strategy in the Treatment of Advanced Soft-Tissue Sarcoma
por: Moore, Donald C., et al.
Publicado: (2018)

Prediction tools for the personalized management of soft-tissue sarcomas of the extremity
por: Acem, Ibtissam, et al.
Publicado: (2022)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study
por: Sleijfer, S, et al.
Publicado: (2012)

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
por: Canter, Robert J, et al.
Publicado: (2014)

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
por: Kilvaer, Thomas K, et al.
Publicado: (2014)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013)

A quest for therapeutic antigens in bone and soft tissue sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021)

Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new
por: Frezza, Anna Maria, et al.
Publicado: (2017)

New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy
por: Pavlidis, Efstathios T, et al.
Publicado: (2023)

The new science of asset allocation: risk management in a multi-asset world
por: Schneeweis, Thomas, et al.
Publicado: (2010)

PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
por: Bertucci, François, et al.
Publicado: (2019)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Soft Tissue Sarcomas of the Kidney
por: Köhle, Olivia, et al.
Publicado: (2015)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research
por: Lee, Che-Jui, et al.
Publicado: (2021)

The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma
por: Stefano, Sioletic, et al.
Publicado: (2019)

ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma
por: Tanaka, Miwa, et al.
Publicado: (2023)

Mechanisms of Chemopreventive and Therapeutic Proprieties of Ginger Extracts in Cancer
por: Zadorozhna, Mariia, et al.
Publicado: (2021)

Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets
por: Kim, Jihyun, et al.
Publicado: (2018)

Molecular landscape and therapeutic alterations in Asian soft‐tissue sarcoma patients
por: Gan, Meifu, et al.
Publicado: (2022)

Molecular blockade of angiogenic factors: A new therapeutic tool for the treatment of abnormal uterine bleeding
por: Ghosh, Subhasish, et al.
Publicado: (2013)

Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
por: Barretina, Jordi, et al.
Publicado: (2010)

Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy
por: Tazawa, Hiroshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_18i7gstt8di4lq0e3r46t7k6hq